In particular, patients with metabolic diseases like T2D and obesity showed chronic inflammation with a low level of serum adiponectin, while autoimmune disease patients (including those with RA and CKD) had chronic inflammation with a high level of serum adiponectin. Here, ADIPOQ is linked to metabolic disease.